Sanket Koul, Business Standard

Stories by Sanket Koul, Business Standard

'Don't Consider Gold, Silver As Asset Classes'

'Don't Consider Gold, Silver As Asset Classes'

Rediff.com   11 Nov 2025

'An asset must generate income. Equities yield dividends, bonds pay coupons, deposits give interest, and real estate earns rent.' 'Gold, silver, and even Bitcoin produce no income, they merely store value. So, they should not be compared to productive assets.'

World's Top Schools Set Sights On India

World's Top Schools Set Sights On India

Rediff.com   3 Nov 2025

In the academic year 2024-2025, the IB had 258 authorised schools in India, up from 183 schools in 2019.

Centre Moves To Bar Drugmakers Over Fake Information

Centre Moves To Bar Drugmakers Over Fake Information

Rediff.com   3 Nov 2025

At present, there is no provision under Drugs Rules, 1945 to address issues of wrong information to obtain regulatory approvals.

'Banks Need To Reinvent Themselves'

'Banks Need To Reinvent Themselves'

Rediff.com   3 Nov 2025

'Reinvention is not a hugely difficult task. With technology as available today, you can reinvent yourself pretty quickly.'

UPI Goes Global, Fintech Hits A Wall

UPI Goes Global, Fintech Hits A Wall

Rediff.com   1 Nov 2025

'When you think of cross-border payments, the first things that come to mind are risk, compliance, taxation, speed, and cost.'

Fresh Air Becomes Real Estate Must-Have

Fresh Air Becomes Real Estate Must-Have

Rediff.com   1 Nov 2025

Interest in green living is rising, with clean air and open spaces becoming key selling points for residential projects, particularly as Indian cities struggle with deteriorating air quality.

JLR Cyberattack Triggers $2.55 Billion Shockwave

JLR Cyberattack Triggers $2.55 Billion Shockwave

Rediff.com   23 Oct 2025

At an estimated 1.9 billion in losses and over 5,000 UK organisations affected, the Jaguar Land Rover cyberattack has been labelled the most economically damaging cyber incident in UK history, exposing the deep vulnerability of interconnected supply chains.

Realty developers see a cracker of sales in key cities this festival season

Realty developers see a cracker of sales in key cities this festival season

Rediff.com   22 Oct 2025

India's housing market has remained resilient this festival season (Dussehra-Diwali period), despite global macroeconomic challenges, tech-sector layoffs, and affordability pressures, with developers reporting 10-25 per cent year-on-year (Y-o-Y) rise in home sales across major cities.

Realty's Next Address: SPR, Sohna Power NCR's Growth

Realty's Next Address: SPR, Sohna Power NCR's Growth

Rediff.com   18 Oct 2025

Part-I of this three-part series dives into Delhi-NCR's SPR, Sohna, Dwarka Expressway, and Jewar Airport leading the charge.

Pilot Training In India Is Below The Mark

Pilot Training In India Is Below The Mark

Rediff.com   14 Oct 2025

The principal problem lies in lack of training infrastructure and relatively lax safety standards.

Will festive season bring cheers to India's housing sector after 3 weak quarters?

Will festive season bring cheers to India's housing sector after 3 weak quarters?

Rediff.com   13 Oct 2025

After three straight quarters of decline, India's housing market is pinning hopes on the ongoing festival season to revive sales momentum. While 2025 may still end with sales volumes below 2024 levels, developers believe the seasonally strong October-December quarter could narrow the gap, aided by stable interest rates, festive incentives, and resilient demand in the premium segment.

Cough syrup deaths: No state follows pharma safety norms

Cough syrup deaths: No state follows pharma safety norms

Rediff.com   10 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.

UK Opens Up For Indian Students

UK Opens Up For Indian Students

Rediff.com   8 Oct 2025

'Initiatives such as the Young Professionals Scheme also offer young graduates the chance to live and work in the UK after gaining experience.'

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Rediff.com   8 Oct 2025

The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage.

Good news for central govt employees on healthcare front

Good news for central govt employees on healthcare front

Rediff.com   7 Oct 2025

Now a multi-dimensional rate structure has been created for CGHS cardholders in all categories based on four different parameters, with semi-private rooms forming the base for package rates.

Cough Syrup For Kids: Centre Tightens Rules

Cough Syrup For Kids: Centre Tightens Rules

Rediff.com   4 Oct 2025

Health ministry advisory urges rational use of cough syrups in children after 11 deaths in Madhya Pradesh and Rajasthan.

Gold, Silver Shine As Stocks Slip

Gold, Silver Shine As Stocks Slip

Rediff.com   1 Oct 2025

'The frenzy for gold is primarily due to the uncertainty surrounding the tariff war.'

Delhi diagnostic players oppose genetic sample outflow ban

Delhi diagnostic players oppose genetic sample outflow ban

Rediff.com   29 Sep 2025

The Delhi government's directive banning sending of genetic samples outside the city for advanced prenatal tests has hit opposition, with diagnostic players in the capital citing operational difficulties in complying with the order. This comes after the Annual Report on Registration of Births and Deaths in Delhi 2024 indicated that the city's sex ratio at birth (SRB) had dropped to 920 girls per 1,000 boys in 2024, down from 922 in 2023.

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com   29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

Drugmakers look to fill Rs 600 cr Novo vacuum

Drugmakers look to fill Rs 600 cr Novo vacuum

Rediff.com   25 Sep 2025

Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of the human insulin pen market by the end of this year and creates an opportunity estimated to be worth Rs 600-800 crore in the domestic market. Some self-use disposable pens are pre-filled with insulin and others can be reused with new cartridges.